On July 6, ImmunityBio fell 5.16% in regular trading, trading at $8.685 USD/share, with Turnover of $36.44 million.
Within the Biotechnology sector where ImmunityBio belongs, the sector broadly declined. Among individual stocks, Gilead Sciences down 2.37%, AbbVie down 1.83%, Moderna, Inc. up 1.52%, Amgen down 3.30%, Vertex Pharmaceuticals down 2.07%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)